HIV-1-infection Clinical Trials in San Francisco, California
7 recruitingSan Francisco, California
Showing 1–7 of 7 trials
Recruiting
Phase 2
HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study
HIV-1-infection
TaiMed Biologics Inc.75 enrolled10 locationsNCT07215468
Recruiting
Phase 1
Study of GS-3242 in Participants With HIV-1; Substudy-05
HIV-1-infection
Gilead Sciences30 enrolled28 locationsNCT07001319
Recruiting
Phase 1
Safety Study of MucoCept-CVN
HIV-1-infection
Craig Cohen, MD, MPH12 enrolled1 locationNCT07181486
Recruiting
Phase 1
PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)
HIV-1-infection
University of California, San Francisco30 enrolled1 locationNCT03729752
Recruiting
Observational PIC Destination Cohort
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections30 enrolled4 locationsNCT05985642
Recruiting
Phase 2
PrEPsmart 2-1-1 Pilot
HIV-1-infection
Public Health Foundation Enterprises, Inc.60 enrolled1 locationNCT06631365
Recruiting
Early Phase 1
Pharmacokinetics Distribution of Raltegravir by PET/MR
HIV-1-infection
University of California, San Francisco10 enrolled1 locationNCT03174977